First, I need to figure out the diagnosis. The key symptoms here are the fluctuating muscle weakness that worsens with activity and improves with rest, and the fact that edrophonium (a short-acting acetylcholinesterase inhibitor) helps. This points to myasthenia gravis. The classic presentation includes ocular symptoms (like diplopia and ptosis) that are worse later in the day, which fits. The edrophonium test is a hallmark for MG.
Now, the question is about the most likely lab finding. Sjogren's syndrome is an autoimmune condition, and MG is also autoimmune. Patients with Sjogren's can have associated autoimmune disorders. In MG, the primary lab finding is the presence of acetylcholine receptor antibodies (AChR antibodies). These antibodies block or destroy the ACh receptors at the neuromuscular junction, leading to the weakness. So, the expected lab finding here would be positive AChR antibodies.
Looking at the options, the correct answer would be the one that mentions AChR antibodies. The other options might include things like antinuclear antibodies (common in Sjogren's), but the question is about the lab finding related to the current condition, which is MG. Another possible distractor could be anti-SSA/SSB antibodies, which are seen in Sjogren's, but the question is about the MG diagnosis. Also, other autoimmune markers like anti-MuSK antibodies could be present in a subset of MG patients without AChR antibodies, but AChR is the most common.
Wait, the patient has Sjogren's, so maybe there's a connection. Sjogren's is associated with other autoimmune conditions. But the key here is the response to edrophonium, which confirms MG. So the lab finding specific to MG is AChR antibodies. The presence of Sjogren's might mean the patient has a higher risk for developing MG, which is a known association. Therefore, the most likely lab result is positive AChR antibodies.
**Core Concept**
The clinical scenario describes a patient with symptoms consistent with myasthenia gravis (MG), an autoimmune neuromuscular disorder characterized by fluctuating muscle weakness due to autoantibodies against acetylcholine receptors (AChRs). The key diagnostic clue is the positive response to edrophonium, a short-acting acetylcholinesterase inhibitor that temporarily improves neuromuscular transmission by increasing acetylcholine availability.
**Why the Correct Answer is Right**
The patient’s symptoms of ocular weakness worsening with activity (fatigable weakness), improvement with edrophonium, and no joint/muscle pain are classic for MG. The primary pathophysiology involves autoantibodies targeting postsynaptic AChRs at the neuromuscular junction, leading to impaired signal transmission. The most specific laboratory finding in MG is the presence
Free Medical MCQs · NEET PG · USMLE · AIIMS
Access thousands of free MCQs, ebooks and daily exams.
By signing in you agree to our Privacy Policy.